Dale DC - Search Results

1

The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report.

Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K. Dale DC, et al. Support Cancer Ther. 2006 Jul 1;3(4):220-31. doi: 10.3816/SCT.2006.n.020. Support Cancer Ther. 2006. PMID: 18632498

2

Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias.

Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A, Welte K. Bonilla MA, et al. Br J Haematol. 1994 Dec;88(4):723-30. doi: 10.1111/j.1365-2141.1994.tb05110.x. Br J Haematol. 1994. PMID: 7529539 Clinical Trial.

3

Cyclic neutropenia: natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor.

Dale DC, Bolyard AA, Hammond WP. Dale DC, et al. Cancer Invest. 1993;11(2):219-23. doi: 10.3109/07357909309024842. Cancer Invest. 1993. PMID: 7681723 Clinical Trial. No abstract available.

4

Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor.

Jones EA, Bolyard AA, Dale DC. Jones EA, et al. Among authors: dale dc. JAMA. 1993 Sep 1;270(9):1132-3. doi: 10.1001/jama.270.9.1132. JAMA. 1993. PMID: 7688828

5

Hematopoietic growth factors for the treatment of severe chronic neutropenia.

Dale DC. Dale DC. Stem Cells. 1995 Mar;13(2):94-100. doi: 10.1002/stem.5530130201. Stem Cells. 1995. PMID: 7787781 Review.

6

A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P, et al. Dale DC, et al. Blood. 1993 May 15;81(10):2496-502. Blood. 1993. PMID: 8490166 Free PMC article. Clinical Trial.

7

Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.

Kalra R, Dale D, Freedman M, Bonilla MA, Weinblatt M, Ganser A, Bowman P, Abish S, Priest J, Oseas RS, Olson K, Paderanga D, Shannon K. Kalra R, et al. Blood. 1995 Dec 15;86(12):4579-86. Blood. 1995. PMID: 8541548 Free article.

8

Pathophysiology and treatment of severe chronic neutropenia.

Welte K, Dale D. Welte K, et al. Ann Hematol. 1996 Apr;72(4):158-65. doi: 10.1007/s002770050156. Ann Hematol. 1996. PMID: 8624368 Review.

9

Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.

Dong F, Dale DC, Bonilla MA, Freedman M, Fasth A, Neijens HJ, Palmblad J, Briars GL, Carlsson G, Veerman AJ, Welte K, Löwenberg B, Touw IP. Dong F, et al. Among authors: dale dc. Leukemia. 1997 Jan;11(1):120-5. doi: 10.1038/sj.leu.2400537. Leukemia. 1997. PMID: 9001427

10

Congenital neutropenia and the risk of leukemia.

Boxer LA, Dale D. Boxer LA, et al. J Pediatr. 1997 Feb;130(2):335. doi: 10.1016/s0022-3476(97)70374-3. J Pediatr. 1997. PMID: 9042149 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters